Kenya Biovax Institute Appoints Dr Michael Lusiola As CEO
Dr Michael Lusiola has been appointed as the CEO/Director-General of Kenya BioVax Institute (KBI) effective June 2022. He takes over…
Dr Michael Lusiola has been appointed as the CEO/Director-General of Kenya BioVax Institute (KBI) effective June 2022. He takes over…
No more posts available. Thank you for scrolling this far.
No more posts available. Thank you for scrolling this far.